Cancer Institute Clinical Trials - Gastrointestinal

Colorectal

#120549 NCT01765582
Title:
STEAM (SEQUENTIAL TRIPLET AND AVASTIN MAINTENANCE): FOLFOXIRI/BEVACIZUMAB REGIMENS (CONCURRENT AND SEQUENTIAL) VS. FOLFOX/BEVACIZUMAB IN FIRST-LINE METASTATIC COLORECTAL CANCER
Study Location:
Temple Main Campus
Indication
: Metastatic Colorectal Cancer

#90569 NCT00608361
Title: Dasatinib in Treating Patients with Metastatic or Unresctable Solid Tumor or Lymphoma
Study Location: Temple Main Campus

#130111 NCT01515787
Title: A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision
Study Location: Temple Main Campus

#100515 NCT01150045
Title: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer 
Study Location: Temple Main Campus

Pancreatic

#110012 NCT01013649
Title: A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment For Patients With Resected Head of Pancreas Adenocarcinoma
Study Location: Temple Main Campus

For more information or to enroll in a study, please call 254-724-5407.

 


Print
Text Size
A
A
A